Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ELUT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Guido J. Neels Director | ELUT Elutia, Inc. | Buy | 20,000 | $1.04 | $20.8K Buy | Form 4 ↗ |
| Jan 30, 2026 | Kevin Rakin Director, 10% owner | ELUT Elutia, Inc. | Buy | 70,000 | $1.06 | $74.2K Buy | Form 4 ↗ |
| Jan 29, 2026 | Guido J. Neels Director | ELUT Elutia, Inc. | Buy | 15,000 | $1.06 | $15.9K Buy | Form 4 ↗ |
| Jan 28, 2026 | Guido J. Neels Director | ELUT Elutia, Inc. | Buy | 15,000 | $1.06 | $15.9K Buy | Form 4 ↗ |
| Dec 17, 2025 | David Colpman Director | ELUT Elutia, Inc. | Buy | 12,500 | $0.51 | $6,375 Buy | Form 4 ↗ |
| Dec 17, 2025 | Brigid Makes Director | ELUT Elutia, Inc. | Buy | 25,000 | $0.52 | $13.0K Buy | Form 4 ↗ |
| Dec 17, 2025 | C. Randal Mills PRESIDENT AND CEO, Director | ELUT Elutia, Inc. | Buy | 3,000 | $0.51 | $1,530 Buy | Form 4 ↗ |
| Dec 17, 2025 | Matthew Ferguson CHIEF FINANCIAL OFFICER | ELUT Elutia, Inc. | Buy | 60,000 | $0.53 | $31.8K Buy | Form 4 ↗ |
| Dec 17, 2025 | HighCape Partners GP II, LLC 10% owner | ELUT Elutia, Inc. | Buy | 50,000 | $0.52 | $26.0K Buy | Form 4 ↗ |
| Dec 2, 2025 | Matthew Ferguson CHIEF FINANCIAL OFFICER | ELUT Elutia, Inc. | Buy | 5,500 | $0.67 | $3,685 Buy | Form 4 ↗ |
| Dec 1, 2025 | Matthew Ferguson CHIEF FINANCIAL OFFICER | ELUT Elutia, Inc. | Buy | 4,500 | $0.65 | $2,925 Buy | Form 4 ↗ |
| Nov 24, 2025 | C. Randal Mills PRESIDENT AND CEO, Director | ELUT Elutia, Inc. | Buy | 5,000 | $0.60 | $3,000 Buy | Form 4 ↗ |
| Nov 17, 2025 | David Colpman Director | ELUT Elutia, Inc. | Buy | 15,500 | $0.74 | $11.5K Buy | Form 4 ↗ |
| Nov 13, 2025 | C. Randal Mills PRESIDENT AND CEO, Director | ELUT Elutia, Inc. | Buy | 3,500 | $0.76 | $2,660 Buy | Form 4 ↗ |
| Nov 13, 2025 | C. Randal Mills PRESIDENT AND CEO, Director | ELUT Elutia, Inc. | Buy | 5,000 | $0.75 | $3,750 Buy | Form 4 ↗ |
| Nov 13, 2025 | C. Randal Mills PRESIDENT AND CEO, Director | ELUT Elutia, Inc. | Buy | 5,000 | $0.74 | $3,700 Buy | Form 4 ↗ |
| Feb 3, 2025 | HighCape Capital, L.P. Director, 10% owner | ELUT Elutia, Inc. | Buy | 420,000 | $2.50 | $1.1M Buy | Form 4 ↗ |
| Feb 3, 2025 | Highcape Partners, L.P. 10% owner | ELUT Elutia, Inc. | Buy | 420,000 | $2.50 | $1.1M Buy | Form 4 ↗ |
18 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:34 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances